Researchers have demonstrated how a non-toxic alternative to lead could form the basis of next-generation solar cells.
In this piece for The Conversation, Carlos López-Gómez from Cambridge's Institute for Manufacturing, discusses the role that small and medium-sized businesses might play in a post-Brexit economy.
Negative media coverage of the side effects associated with taking statins, and patients’ own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially life-saving drugs, according to research published today.
Jane Austen fans will have a rare chance today (18 July 2017) to see the manuscript of the novelist’s final (unfinished) novel at King’s College. The one-day exhibition in the College's Old Library marks Austen’s death 200 years ago and is open to the public.
Gene editing using ‘molecular scissors’ that snip out and replace faulty DNA could provide an almost unimaginable future for some patients: a complete cure. Cambridge researchers are working towards making the technology cheap and safe, as well as examining the ethical and legal issues surrounding one of the most exciting medical advances of recent times.
An open source, 3D-printable microscope that forms the cornerstone of rapid, automated water testing kits for use in low and middle-income countries, has helped a Cambridge researcher and his not-for-profit spin-out company win the top prize in this year’s Vice-Chancellor’s Impact Awards at the University of Cambridge.
Smoking, lack of exercise, bad diet and our genes are all well-known risk factors for heart disease, cancer and diabetes. But, as researchers are beginning to understand, the environment in the womb as we first begin to grow may also determine our future.